United States Oil & Gas Corp (PINKSHEETS: USOG) strategically acquired United Oil of North Dakota earlier this month putting the company in a position to benefit from the Bakken Formation which covers nearly 200,000 square miles.

Technically recoverable oil has been quoted as low as 2.1 billion barrels to a high of 503 billion barrels. The most recent report issued by the state of North Dakota states 167 billion barrels of oil.

The US Oil & Gas subsidiary based in Bottineau County, is situated in a perfect position to capitalize on the attention the Bakkan Formation is drawing. The increased activity to the area should provide a boost to the oil and gas business, convenience store usage, and the ability to incorporate drilling activities.

For more information visit www.stocksource.us/usog.html

Other active stocks are Cyclacel Pharmaceuticals (NASDAQ: CYCC), Lexican Pharmaceuticals (NASDAQ: LXRX) and GenVec Inc (NASDAQ: GNVC).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation do no trading of any kind and send no faxes or emails.

Contact: Eric Jensen www.ionewswire.com 516.942.4910

Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Lexicon Pharmaceuticals Charts.
Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Lexicon Pharmaceuticals Charts.